Logo CUTISS News final

University of Zurich receives Swissmedic approval

University of Zurich receives Swissmedic approval to commence phase II denovoSkin™ trial for reconstructive surgery in adults and children.
Scroll to Top

Newsletter

Would you like to contact us as a journalist?

This website uses cookies to ensure you get the best experience on our website.